Keywords: کارسینوم هپاتوسلولار; ASA, American Society of Anesthesiology; HCC, hepatocellular carcinoma; LA, laparoscopic adrenalectomyAdrenalectomy; Laparoscopy; Large tumour
مقالات ISI کارسینوم هپاتوسلولار (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارسینوم هپاتوسلولار; CC, Cryptogenic cirrhosis; CEP, Chromosome enumeration probes; FISH, Fluorescence in situ hybridization; HCC, Hepatocellular carcinoma; NAFLD, Non-alcoholic fatty liver disease; NASH, Non-alcoholic steatohepatitis; PBS, Phosphate buffered saline; TA, Telo
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; IR, immune repertoire; CDR, complementarity-determining regions; TCRs, T cell receptors; BCRs, B cell receptors; MRD, minimal residual disease; HTS, high-throughput sequencing; IR-SEQ, immune repertoire sequencing; TILs, tum
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; OS, overall survival; C-P, Child-Pugh; ALBI, albumin-bilirubin; BCLC, Barcelona Clinic Liver Cancer; AFP, α-fetoproteinHepatocellular carcinoma; Barcelona Clinic Liver Cancer; Overall survival; Albumin-bilirubin score; Curat
Keywords: کارسینوم هپاتوسلولار; ALLN, acetyl-leucyl-leucyl-norleucinal; ATF6, activating transcription factor 6; BCS, bathocuproine disulfonate; ER, endoplasmic reticulum; GO, glucose oxidase; HCC, hepatocellular carcinoma; H2DCFDA, 2′,7′-dichlorodihydrofluorescein diacetate; IRE1α, ino
Keywords: کارسینوم هپاتوسلولار; GD, Gaucher disease; HCC, hepatocellular carcinoma; MRI, magnetic resonance imaging; CT, computed tomography; US, ultrasound; FNH, focal nodular hyperplasia; SSI, severity score index; ERT, enzyme replacement therapy; SRT, substrate reduction therapyGauch
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; CT, computed tomography; GSI, gem stone imaging; DECT, dual energy computed tomography; LLR, lesion to liver parenchyma ratio; MMD, monochromatic material density; CI, confidence intervalHepatocellular carcinoma; Dual energy
Keywords: کارسینوم هپاتوسلولار; Andro, andrographolide; ERK, extracellular regulated kinase; HCC, Hepatocellular carcinoma; HPLC, high pressure liquid chromatography; JNK, c-Jun N-terminal kinase; KEGG, Kyoto Encyclopedia Genes $amp Genomes; MPAKs, mitogen-activated protein kinases; miR
Keywords: کارسینوم هپاتوسلولار; Liver Cancer; Metastasis; Spread; PathogenesiscHCC-ICC, combined hepatocellular and intrahepatic cholangiocarcinoma; CNV, copy number variation; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; ICC, intrahepatic cholangiocarcinoma; IM, intrahepatic
Keywords: کارسینوم هپاتوسلولار; PVT, portal vein thrombosis; LC, liver cirrhosis; HCC, hepatocellular carcinoma; CTP, cavernous transformation of the PV; HFL, hepatic focal lesion; HFLs, hepatic focal lesions; SI, signal intensityPortal vein thrombosis; Color Doppler; Triphasic CT; MR D
Keywords: کارسینوم هپاتوسلولار; AFP, alpha fetoprotein; ALP, alkaline phosphatase; BCLC, Barcelona-Clinic Liver Cancer; CLIP, Cancer of the Liver Italian Program; DEN, diethylnitrosamine; GEO, Gene Expression Omnibus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; TCA, tricarbox
Keywords: کارسینوم هپاتوسلولار; Nonalcoholic Fatty Liver Disease; Nonalcoholic Steatohepatitis; Children; AdultsALT, alanine aminotransferases; HCC, hepatocellular carcinoma; NAFLD, nonalcoholic fatty liver disease; NHANES, National Health and Nutrition Examination Survey; NAS, NAFLD Ac
Keywords: کارسینوم هپاتوسلولار; Organoselenium; Diselenides; Quinone; Tetrazole; Azido-Ugi reaction; Redox modulators; Caspase-8; Apoptosis; Ki-67; Bcl-2DOS, diversity-oriented synthesis; OS, oxidative stress; HCC, hepatocellular carcinoma; MCF-7, breast adenocarcinoma; SN, nucleophilic
Keywords: کارسینوم هپاتوسلولار; BMI, body mass index; BPAR, biopsy proved acute rejection; CNI, calcineurin inhibitor; DM, diabetes mellitus; ESLD, end stage liver disease; HCC, hepatocellular carcinoma; LT, liver transplantation; MELD, model of end stage liver disease; MMF, mycophenola
Keywords: کارسینوم هپاتوسلولار; AIH, autoimmune hepatitis; APRI, aspartate transaminases to platelet ratio index; CMV, cytomegalovirus; EBV, Epstein bar virus; HCC, hepatocellular carcinoma; HEV, hepatitis E virus; INCPH, idiopathic noncirrhotic portal hypertension; LB, liver biopsy; LD
Keywords: کارسینوم هپاتوسلولار; Hepatocellular carcinoma (HCC); Transarterial chemoembolization (TACE); Biliary complications; BilomaTACE, transarterial chemoembolization; HCC, hepatocellular carcinoma; AFP, alpha-fetoprotein; MDCT, multi-detector computed tomography; MRI, magnetic reso
Keywords: کارسینوم هپاتوسلولار; DW, diffusion-weighted; MR, magnetic resonance; ADC, apparent diffusion coefficient; CT, computed tomography; NASH, nonalcoholic steatohepatitis; HCC, hepatocellular carcinoma; ROI, region of interestHemangioma; Cirrhosis; Chronic liver disease; Diffusion
Keywords: کارسینوم هپاتوسلولار; AFP, alpha-fetoprotein; BMI, body-mass index; CEA, cancer embryo antigen; CK1, casein kinase 1; GSD, glycogen storage disease; GSK3β, glycogen synthase kinase; HBsAg, Hepatitis B surface antigen; HCA, hepatocellular adenoma; HCC, hepatocellular carcinoma;
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; LT, liver transplantation; MELD, Model for End-Stage Liver Disease; UNOS, United Network for Organ Sharing
Keywords: کارسینوم هپاتوسلولار; CI, Confidence Interval; EP, Equilibrium phase; Gd-BOPTA, Gadobenate dimeglumine; Gd-EOB-DTPA, Gadoxetic acid; HBP, Hepatobiliary phase; HAP, Hepatic arterial phase; HCC, Hepatocellular carcinoma; CC, Cholangiocarcinoma; OR, Odds Ratio; PVP, Portal venous
Keywords: کارسینوم هپاتوسلولار; MELD, Model for End-stage Liver Disease; UNOS, United Network for Organ Sharing; INR, International Normalized Ratio of the prothrombin time; LT, liver transplantation; MBT, methacetin breath test; HCC, hepatocellular carcinoma; CPDR, cumulative percent d
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; HBsAg, hepatitis B surface antigen; anti-HCV, antibody to HCV; NHI, national health insurance; NATP, National Antiviral Treatment Program; ICD-O-3, International Classification
Keywords: کارسینوم هپاتوسلولار; ALT, Alanine Transaminase; AST, Aspartate Transaminase; BMI, Body Mass Index; FBG, fasting blood glucose; HCC, hepatocellular carcinoma; HC, hip circumference; HDL, high-density lipoprotein; HOMA-B, beta-cell function; HOMA, Homeostatic Model Assessment;
Keywords: کارسینوم هپاتوسلولار; BCLC, Barcelona clinic liver cancer; HCC, hepatocellular carcinoma; RCC, renal cell carcinoma; CECT, contrast enhanced computed tomography; CEMRI, contrast enhanced magnetic resonance imaging; US, ultrasound; CEUS, contrast enhanced ultrasound; EFSUMB, Eu
Keywords: کارسینوم هپاتوسلولار; Fatty Liver; UNOS/OPTN; Waitlist Mortality; MELDALD, alcoholic liver disease; BMI, body mass index; CC, cryptogenic cirrhosis; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HR, hazard ratio; LT, liver transplantation; MELD, Model for End Stage Li
Keywords: کارسینوم هپاتوسلولار; 1-D, one-dimensional; CPMG, Carr-Purcell-Meiboom-Gill 3B; DEN, diethylnitrosamine; FID, free induction decay; 1H, human proton; HCC, hepatocellular carcinoma; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NOESY, nuclear overhauser effect sp
Keywords: کارسینوم هپاتوسلولار; AAL, Aleuria aurantia lectin; AIBN, 2,2′-azobis(isobutyronitrile); CPLL, combinatorial peptide ligand library; DEPs, differentially expressed proteins; GMM, glyceryl methacrylate; HCC, hepatocellular carcinoma; ICAT, isotope coded affinity tags; iTRAQ, is
Keywords: کارسینوم هپاتوسلولار; DFS, disease-free survival; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HR, hazard ratio; LR, liver resection; LT, liver transplantation; MELD, Model for End-Stage Liver Disease; OS, overall survival
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; LT, liver transplantation; CK19, cytokeratin protein 19; HR, hazard Ratio; EpCAM, epithelial cell adhesion molecule; OS, overall survival; miVI, microvascular invasion; TGFb, transforming growth factor-beta; CT, computed tom
Keywords: کارسینوم هپاتوسلولار; CIR, cirrhotic group; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HD, healthy donor; PBMC, peripheral blood mononuclear cells; MoDC, monocyte-derived dendritic cell; AFP, alpha-fetoprotein; GPC3, glypican-3Dendritic cell; Cirrhosis; Hepatitis C
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; FBS, fetal bovine serum; HS, human serum; A1AT, alpha-1 antitrypsin; RIG-I, retinoic acid-inducible gene 1; DMSO, dimethyl sulfoxide; RPS11, ribosomal protein subunit 11; TLR3, toll-like receptor 3; M
Keywords: کارسینوم هپاتوسلولار; Obesity; HCC; Case-Control; Risk FactorBMI, body mass index; CI, confidence interval; CLD, chronic liver disease; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; OR, odds ratio; S, synergetic index
Keywords: کارسینوم هپاتوسلولار; DBD, donation after brain death; DCD, donation after cardiac death; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HTK, histidine-tryptophan-ketoglutarate solution; IC, ischemic cholangiopathy; MELD, Model for End-Stage Liver Disease; OLT, orthoto
Keywords: کارسینوم هپاتوسلولار; Stomach cancer; Liver cancer; Colorectal cancer; Risk factor; ScreeningHBV, Hepatitis B virus; HCC, hepatocellular carcinoma; CHB, chronic hepatitis B; NHIRD, National Health Insurance Research Database
Keywords: کارسینوم هپاتوسلولار; CIT, cold ischemia time; HAT, hepatic artery thrombosis; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HR, hazard ratio; MELD, Model for End-Stage Liver Disease; O, older; OLT, orthotopic liver transplantation; Y, younger
Keywords: کارسینوم هپاتوسلولار; APN, adiponectin; HCC, hepatocellular carcinoma; JNK, C-Jun N-terminal kinase; Trx, thioredoxin; NAC, N-acetylcysteine; AMPK, 5′-adenosine monophosphate-activated protein kinase; ROS, reactive oxygen species; ASK1, apoptosis signal-regulating kinase 1; PC
Keywords: کارسینوم هپاتوسلولار; ALF, acute liver failure; CMV, cytomegalovirus; CT, computerized tomography; DBD, donation after brain death; DCD, donation after cardiac death; DDLT, deceased donor liver transplant; DNA, deoxyribonucleic acid; HCC, hepatocellular carcinoma; HCV, hepatit
Keywords: کارسینوم هپاتوسلولار; AFP, alpha fetoprotein; AJCC, American Joint Committee on Cancer; HCC, hepatocellular carcinoma; HR, hazard ratio; IQR, interquartile range; LT, liver transplantation; MC, Milan criteria; MELD, Model for End-Stage Liver Disease; NASH, nonalcoholic steatoh
Keywords: کارسینوم هپاتوسلولار; ATP, adenosine triphosphate; CagA, cytotoxin-associated gene A; Cx, connexin; GJIC, gap junctional intercellular communication; HCC, hepatocellular carcinoma; mRNA, messenger RNA; Panx, pannexin; VacA, vacuolating toxin A
Keywords: کارسینوم هپاتوسلولار; ChIP, chromatin immunoprecipitation; DMSO, dimethyl sulfoxide; ERK, extracellular regulated protein kinase; FBS, fetal bovine serum; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GFP, green fluorescent protein; HCC, hepatocellular carcinoma; HURP, hepa
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; 18F-FDG-PET, 18F-fluorodeoxyglucose positron emission tomography; AFP, serum alpha-fetoprotein; BCLC, Barcelona clinic liver cancer
Keywords: کارسینوم هپاتوسلولار; radiotherapy in hepatocellular carcinoma; radiation induced liver disease; SBRT; proton beam therapyCRT, conformal radiotherapy; HCC, hepatocellular carcinoma; IGRT, image guided radiotherapy; RFA, radiofrequency ablation; RILD, radiation-induced liver di
Keywords: کارسینوم هپاتوسلولار; AFP, Alfa-fetoprotein; BSEP, Bile salt export pump; CT, Computer tomography; DIC, Disseminated intravascular coagulation; FNH, Focal nodular hyperplasia; HBL, Hepatoblastoma; HCA, Hepatocellular adenoma; HCC, Hepatocellular carcinoma; HNF1a, Hepatocyte nu
Keywords: کارسینوم هپاتوسلولار; Hepatocellular carcinoma; temporomandibular disorders; malignant tumor; metastatic lesionFDG, 18-fluoro-2-deoxyglucose; HCC, Hepatocellular carcinoma; PET-CT, Positron emission tomographic–computed tomographic; TMD, Temporomandibular disorder; TMJ, Tempor
Keywords: کارسینوم هپاتوسلولار; GI, gastrointestinal; RNS, reactive nitrogen species; ROS, reactive oxygen species; HCC, hepatocellular carcinoma; DSS, dextran sulphate sodium; IBD, inflammatory bowel disease; TNBS, 2,4,6-trinitrobenzene sulphonic acid; DNBS, dinitrobenzene sulphonic ac
Keywords: کارسینوم هپاتوسلولار; ICC, intrahepatic cholangiocarcinoma; HCC, hepatocellular carcinoma; AGR3, anterior gradient 3; AGR2, anterior gradient 2; GPC-3, glypican-3; ROC, receiver operating characteristics; AUC, area under curveAGR3; GPC-3; Intrahepatic cholangiocarcinoma; Hepat
Keywords: کارسینوم هپاتوسلولار; hepatocellular carcinoma; liver transplantation; living donor liver transplantation; Milan criteria; UCSF criteriaAFP, alfa-fetoprotein; DDLT, deceased donor transplants; FDG, fluoro-deoxy-glucose; HCC, hepatocellular carcinoma; LDLT, living donor liver t
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; Lap Hx, laparoscopic hepatic resection; ICGR-15, indocyanine green retention rate at 15 minutes; Open-Hx, open hepatic resection
Keywords: کارسینوم هپاتوسلولار; surveillance; hepatocellular carcinoma; prevention; cost effective strategyAFP, alpha-fetoprotein; CI, confidence interval; CLD, chronic liver disease; DCP, des-γ-carboxy-prothrombin; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C
Keywords: کارسینوم هپاتوسلولار; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; TEMs, tetraspanin-enriched microdomains; PI4P, phosphatidylinositol 4-phosphate; PI(4,5)P2, phosphatidylinositol 4,5 bisphosphate; GFP, Green fluorescent protein; TGFβ, transfo